XMAE:XETRA:XETRA-Xtrackers MSCI AC World ESG Screened UCITS ETF 2C - EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 41.57

Change

-0.08 (-0.19)%

Market Cap

N/A

Volume

1.14K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.45 (-0.85%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-0.82%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.85%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.26 (-0.90%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.91%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.22 (-0.48%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-1.56 (-1.10%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.45 (-0.86%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.11 (+0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.50 (+0.08%)

USD 80.38B

ETFs Containing XMAE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.40% 38% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.40% 38% F 38% F
Trailing 12 Months  
Capital Gain 20.83% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.83% 72% C 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.13% 69% C- 68% D+
Dividend Return 11.13% 68% D+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.28% 57% F 65% D
Risk Adjusted Return 98.69% 88% B+ 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike